Dr. Daniel Labow, one of the top peritoneal mesothelioma doctors in the world, has joined the team at Nuvance Health in Danbury, Connecticut. According to an article on the Nuvance Health website, Dr. Labow will be the new Chair of Surgical Services at the institution.
Dr. Labow credited Nuvance as a “young healthcare system” with superb surgical services. Nuvance Health has seven hospitals. It began as a non-profit health care system with three hospitals in western Connecticut – Danbury Hospital, New Milford Hospital and Norwalk Hospital. It has expanded in the last few years after a merger with Health Quest, which had several hospitals in the Hudson Valley region of New York.
“I want people in our communities to know they do not need to travel away from their family, friends and home to access the best possible surgical services and experience,” Dr. Labow said, as quoted on the Nuvance Health website.
Dr. Labow will also serve as chair of surgery at Danbury Hospital and the New Milford Hospital location. Dr. Labow is a board-certified surgeon with a specialty in surgical oncology, including surgery for gastrointestinal cancers such as pancreatic cancer and peritoneal mesothelioma.
At Nuvance Health, Dr. Labow will manage all aspects of surgery, including inpatient and outpatient services and trauma. Dr. Christopher Lehrach, the chief physician executive at Nuvance Health, called Dr. Labow a “nationally renowned health care physician executive and surgeon” with a reputation for developing “cutting-edge surgical care programs.”
“An accomplished leader, Dr. Labow will build on our strengths and recruit new top caliber surgeons and subspecialists to Nuvance Health,” Dr. Lehrach added. “We are delighted that Dr. Labow shares our vision for Nuvance Health — ensuring that unmatched care is available to everyone in the communities we serve.”
One of those cutting-edge surgical programs is the HIPEC surgery approach Dr. Labow led at Mount Sinai Health System, which is where he worked previously for 19 years. This network includes Mount Sinai Hospital and the Tisch Cancer Institute at Mount Sinai. HIPEC stands for hyperthermic intraperitoneal chemotherapy, which is combined with an aggressive cytoreduction surgery to treat peritoneal mesothelioma.
HIPEC with cytoreduction surgery is the main treatment for this cancer, and Dr. Labow developed one of the busiest HIPEC programs in the United States at Mount Sinai.
He was the Executive Vice-Chair and Vice Chair of Quality for the Department of Surgery. Dr. Labow worked closely at Mount Sinai with Dr. Raja Flores, who is a specialist in pleural mesothelioma. Dr. Labow led peritoneal mesothelioma treatment at Mount Sinai.
Dr. Daniel Labow’s Medical Background
Dr. Labow received his Medical Degree in 1995 from the Brown-Dartmouth Medical Program and completed a general surgery residency at the University of Chicago Hospitals.
He then completed a surgical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York City, followed by joining the Mount Sinai Health System staff in 2004. He finished his 19-year tenure there as the Eugene Friedman Endowed Chair in Surgical Oncology.
Dr. Labow recently earned a Master’s Degree in Health Care Quality and Patient Safety from Northwestern University in Chicago.
In addition to being a board-certified surgeon in general surgery, Dr. Labow is a member of the American College of Surgeons, the American Hepatopancreaticobiliary Association, and the Society of Surgical Oncology. He was also the Co-Chair of the Gastrointestinal Disease Focus Group at Mount Sinai.
Sources & Author
- New chair of surgery joins Nuvance Health, comes from Mount Sinai Health System. Nuvance Health. Retrieved from: https://www.nuvancehealth.org/health-tips-and-news/daniel-labow-md-new-chair-of-surgical-services. Accessed: 05/18/2023.
Sources & Author
